Start / Plenary Session / 4 65 destiny breast 04 a complex trial to deconstruct

4.65 DESTINY BREAST 04 - A complex trial to deconstruct

32 min • 7 juni 2022

My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low

Kategorier

Hälsa och motion Medicin Poddar Vetenskap

Förekommer på

Vetenskap

00:00 -00:00